ABUS - Arbutus Biopharma Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5101.19M
Enterprise Value 3125.6M
Trailing P/E N/A
Forward P/E 1-1.25
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)19.51
Price/Book (mrq)1.91
Enterprise Value/Revenue 324.21
Enterprise Value/EBITDA 6-1.79

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)-1,394.41%

Management Effectiveness

Return on Assets (ttm)-18.87%
Return on Equity (ttm)-30.40%

Income Statement

Revenue (ttm)5.19M
Revenue Per Share (ttm)0.09
Quarterly Revenue Growth (yoy)-52.70%
Gross Profit (ttm)-51.99M
EBITDA -70.25M
Net Income Avi to Common (ttm)-73.35M
Diluted EPS (ttm)-1.3220
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)110.59M
Total Cash Per Share (mrq)1.95
Total Debt (mrq)3.87M
Total Debt/Equity (mrq)2.14
Current Ratio (mrq)12.75
Book Value Per Share (mrq)0.93

Cash Flow Statement

Operating Cash Flow (ttm)-64.48M
Levered Free Cash Flow (ttm)-38.74M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.16
52-Week Change 3-73.94%
S&P500 52-Week Change 35.62%
52 Week High 312.6000
52 Week Low 31.4200
50-Day Moving Average 32.0657
200-Day Moving Average 33.3882

Share Statistics

Avg Vol (3 month) 3341.69k
Avg Vol (10 day) 3487.9k
Shares Outstanding 556.85M
Float 31.46M
% Held by Insiders 140.87%
% Held by Institutions 144.06%
Shares Short (May 31, 2019) 41.28M
Short Ratio (May 31, 2019) 44.35
Short % of Float (May 31, 2019) 43.43%
Short % of Shares Outstanding (May 31, 2019) 42.21%
Shares Short (prior month Apr 30, 2019) 4994.92k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 25/1
Last Split Date 3Nov 4, 2010